Isotopia backs development of 'virtual' biopsy

2019 01 05 00 38 5275 Molecular Imaging 400

Isotopia Molecular Imaging has announced it is backing research led by Israeli investigators who are developing a radiopharmaceutical to detect small, aggressive cancerous tumors.

The research is focused on a hypoxia radioactive marker based on a copper-64 isotope that reportedly identifies oxygen-deficient cells. Studies have shown that oxygen concentration in the cell is directly related to the aggressiveness of cancerous tumors.

The hypoxia radioactive marker may determine if a tumor is malignant or benign and also show how aggressive it is through a single image, eliminating the need for a standard biopsy, the company said in a release.

The research is led by Sharon Ruthstein, PhD, of the department of chemistry at Bar-Ilan University in Ramat Gan.

Page 1 of 593
Next Page